Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5715645-cyclohexadecen-1-oneMeSH

  structure in first source

• C5757015-deprenyllupulonol CMeSH

  from Hop (Humulus lupulus L.); structure in first source

• C5743325-desmethyl donepezilMeSH

  structure in first source

• C5713175-epi-dihydrolyfoline N-oxideMeSH

  from Lagerstroemia indica L; structure in first source

• C5809065-ethoxy-2-(2-(morpholin-4-ium-4-yl)ethylsulfanyl)-1H-benzimidazol-3-ium dichlorideMeSH

  structure in first source

• C5847685-ethoxycarbonyl-6-methyl-4-(3-nitrophenyl)-3,4-dihydropyrimidin-2-(1H)-thioneMeSH

  structure in first source

• C5835015-ethoxymethyl-1-carboxyl propyl-1H-pyrrole-2-carbaldehydeMeSH

  from Trichosanthes kirilowii Maxim; structure in first source

• C5685435-ethyl-1-phenyl-2-(1H) pyridoneMeSH
• C5789565-ethyl-3-methyl-6-(1-methyl-1H-pyridin-2-ylidenemethyl)phenanthridiniumMeSH

  an antineoplastic agent; structure in first source

• C5710325-ethyl-5-(piperidin-1-yl)-1,3-diazinane-2,4,6-trioneMeSH

  structure in first source

• C5710335-ethyl-5-(piperidin-1-yl)barbituric acidMeSH

  structure in first source

• C5797105-ethylsulfonyl-2-(o-chlorobenzyl)benzoxazoleMeSH

  has antibacterial activity; structure in first source

• C5691005-ethynyl-2'-deoxycytidine triphosphateMeSH

  used as a probe for detecting cytosine incorporation in DNA; structure in first source

• C5827825-ethynylcytidineMeSH

  used for detecting RNA synthesis via reaction with fluorescent azides; structure in first source

• C5768275-fluoro-2'-deoxyuridineMeSH

  structure in first source

• C5793675-fluoro-2-N,4-N-diphenylpyrimidine-2,4-diamineMeSH

  suppresses cell viability and spindle assembly checkpoint activity by targeting Aurora kinases; structure in first source

• C5809725-fluoro-2-benzoyloxycinnamaldehydeMeSH

  has antineoplastic activity; structure in first source

• C5712945-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid 4-(5-thioxo-5H-1,2-dithiol-3-yl)-phenyl esterMeSH

  a hydrogen sulfide-releasing NSAID with antineoplastic activity; structure in first source

• C5857395-fluoro-2-methyl-N-(2-methyl-4-(2-methyl(1,3')bipyrrolidinyl-1'-yl)phenyl)benzamideMeSH

  structure in first source

• C5870135-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-imidazol-2-yl)-8,9-dihydro-2H-pyrido(4,3,2-de)phthalazin-3(7H)-oneMeSH

  structure in first source

• C5759775-fluoro-methanoprolineMeSH

  structure in first source

• C5609735-formylcytosineMeSH

  structure in first source

• C5717205-furan-2yl-isoxazole-3-carboxylic acid (3-imidazol-1yl-propyl)-amideMeSH

  an agonist of the Wnt-beta-catenin pathway; structure in first source

• C5836145-hexadecenyl acetateMeSH

  isolated from the moth Stathmopoda auriferella; structure in first source

• C5877415-hydoxy-2-(3-hydroxypropyl)-8,8-dimethylpyrano(2,3-f)chromen-4(8H)-oneMeSH

  antiviral from the stem of Cassia siamea; structure in first source

• C5759575-hydroxy-1,1-diphenylpenteneMeSH

  structure in first source

• C5778935-hydroxy-1,2,3,4,4a,9a-hexahydro-1,4-ethano-9,10-anthraquinoneMeSH

  structure in first source

• C5845335-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(5-methylfuran-2-yl)hepta-1,4,6-trien-3-oneMeSH

  structure in first source

• C5619545-hydroxy-2-(2-(4-hydroxyphenyl) acetyl)-3-methoxylbenzoic acidMeSH

  from Acacia catechu, structure in first source

• C5883835-hydroxy-2-methylchroman-4-oneMeSH

  has antineoplastic activity; isolated from Cryptosporiopsis; structure in first source

• C5823615-hydroxy-3,7-dimethoxy-4'-(1-hydroxy-3-methylbut-3-en-2-yloxy)flavoneMeSH

  from whole plant of Spiranthes sinensis; structure in first source

• C5846335-hydroxy-3-isopropyl-4-methoxyfuranoneMeSH

  from gorgonian-associated fungus Aspergillus sp.; structure in first source

• C5705895-hydroxy-4-oxo-4H-pyran-2-yl methyl 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylateMeSH

  has free radical scavenging activity; structure in first source

• C5617695-hydroxy-5-methylhydantoinMeSH

  an oxidized thymine lesion; structure in first source

• C5826665-hydroxy-6-(2-(1H-imidazol-4-yl)ethylamino)cholestan-3-olMeSH

  structure in first source

• C5826675-hydroxy-6-(3-(4-aminobutylamino)propylamino)cholest-7-en-3-olMeSH

  structure in first source

• C5786445-hydroxy-6-isopranyl coumarinMeSH

  from the fruits of Peucedanum grande C. B. Clarke; structure in first source

• C5705375-hydroxy-6-methoxy-2-(3',4',5'-trimethoxybenzoyl)quinolineMeSH

  a tubulin polymerization inhibitor; structure in first source

• C5692455-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazoneMeSH

  structure in first source

• C5742365-hydroxy-7-(2'-hydroxypropyl)-2-methylchromoneMeSH

  from Berchemia lineata; structure in first source

• C5841705-hydroxy-7-methoxy-2-(3',4'-dihydroxy)phenoxychromoneMeSH

  estrogenic compound from the leaves of Peltophorum pterocarpum; structure in first source

• C5741595-hydroxy-7-methoxyflavoneMeSH

  structure in first source

• C5618265-hydroxy-8-methoxy-2-phenyl-7-(4-(pyrrolidin-1-yl)butoxy)4H-chromen-4-oneMeSH

  an antitumor synthetic cpd; structure in first source

• C5686115-hydroxy-N,N-diisopropyltryptamineMeSH

  a metabolite of 5-methoxy-N,N-diisopropyltryptamine; a hallucinogenic agent; structure in first source

• C5782775-hydroxyericamycinMeSH

  isolated from Actinoplanes; structure in first source

• C5879705-hydroxyhatomarubigin EMeSH

  structure in first source

• C5779085-hydroxylpiperlongumineMeSH

  from Beauveria bassiana ATCC 7159; structure in first source

• C5759765-hydroxymethanoprolineMeSH

  structure in first source

• C5842415-hydroxyrosiglitazoneMeSH

  a metabolite of rosiglitazone; structure in first source

• C5818475-hydroxytryptamine-tetramethylrhodamineMeSH

  structure in first source